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Abstract
Squamous cell carcinoma in the lung originates from bronchial
epithelial cells that acquire increasingly abnormal phenotypes.
Currently, no known biomarkers are clinically efficient for the
early detection of premalignant lesions and lung cancer. We
sought to identify secretedmolecules produced from squamous
bronchial epithelial cells cultured with organotypic culture
methods. We analyzed protein expression patterns in the apical
surface fluid (ASF) from aberrantly differentiated squamous
metaplastic normal human tracheobronchial epithelial
(NHTBE) and mucous NHTBE cells. Comparative two-dimen-
sional PAGE analysis revealed 174 unique proteins in the ASFof
squamous NHTBE cells compared with normal mucociliary
differentiated NHTBE cells. Among them, 64 well-separated
protein spots were identified by liquid chromatography-
tandem mass spectrometry, revealing 22 different proteins in
the ASF from squamous NHTBE cells. Expression of six of these
proteins [SCC antigen 1 (SCCA1), SCC antigen 2 (SCCA2),
S100A8, S100A9, Annexin I, and Annexin II] in the squamous
NHTBE cells was further confirmed with immunoblot analysis.
Notably, SCCA1 and SCCA2 were verified as being expressed in
squamous metaplastic NHTBE cells but not in normal mucous
NHTBE or normal bronchial epithelium. Moreover, SCCA1 and
SCCA2 expression increased in in vitro lung carcinogenesis
model cell lines with increasing malignancy. In summary, we
identified proteins that are uniquely secreted from squamous
metaplastic primary human bronchial epithelial cells cultured
by the organotypic air-liquid interface method. These ASF
proteins may be used to detect abnormal lesions in the lung
without collecting invasive biopsy specimens. [Cancer Res
2007;67(14):6565–73]
Introduction
Lung cancers are largely classified into two major groups based
on their histopathologic differences: non–small-cell lung cancer,
which is further divided into adenocarcinoma, squamous cell
carcinoma, and large-cell carcinoma; and small-cell lung carcinoma.
Regardless of its subtype, the 5-year survival rate for lung cancer
is only 10% to 15% (1, 2). Disease stage at diagnosis is the most
important prognostic variable, primarily because late-stage disease
is extremely difficult to cure (3, 4). However, there are currently no
known biomarkers that are clinically efficient for the early detection
of premalignant lesions and lung cancer. The identification of
biomarkers for early abnormal changes in the lung epithelia
may help reduce the high mortality rate associated with this
deadly disease.
During the development of squamous cell carcinoma in the lung,
bronchial epithelial cells exhibit a progressive series of morpho-
logically distinct changes: hyperplasia, squamous metaplasia,
dysplasia, carcinoma in situ , and finally invasive squamous cell
carcinoma. However, there are no biomarkers available for
detection of these premalignant changes in the bronchial
epithelium, except for histologic examination of biopsied bronchial
epithelia. Here, we sought to identify secreted molecules that can
be used to monitor these premalignant changes under the
assumption that these morphologic changes are accompanied by
abnormal secretion of multiple proteins and that identifying the
profiles of these proteins will be useful in developing biomarkers
for detecting precancerous or cancerous pulmonary lesions,
particularly premalignant bronchogenic carcinoma.
However, it is often extremely difficult to identify proteins
secreted from epithelial cells because the proteins in bodily fluids,
such as bronchial secretions and bronchial lavage fluid, or in
cancer tissue specimens include many proteins derived from
circulating blood and mixed cell types, including stromal and
inflammatory cells.
To identify proteins uniquely secreted from squamous metapla-
sia of bronchial epithelia, we used an organotypic bronchial
epithelial cell culture system. We previously showed that normal
human tracheobronchial epithelial (NHTBE) cells cultured by a
three-dimensional organotypic culture method (known as the air-
liquid interface) recapitulates the in vivo mucociliary pseudostra-
tified bronchial epithelium (5). Squamous metaplasia is generated
when the same NHTBE cells are grown in retinoic acid (RA)–
deficient medium (6–8).
To identify proteins uniquely secreted from squamous meta-
plastic bronchial epithelia, we compared the secreted protein
profiles, or secretomes, of apical surface fluid (ASF) samples from
metaplastic squamous NHTBE cell cultures and mucociliary
differentiated NHTBE cells. We found that at least 22 proteins in
the ASF from the metaplastic squamous NHTBE cells were distinct
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from those in the ASF from the mucous NHTBE cells. These
proteins, which include SCC antigen 1 (SCCA1), SCC antigen 2
(SCCA2), S100A8, S100A9, Annexin I, and Annexin II, are potential
biomarkers for the detection of early metaplastic changes in
bronchial epithelial cells.
Materials and Methods
Cell culture. NHTBE cells were cultured by air-liquid interface method as
previously described (5–8). Basically, NHTBE cells (Clonetics Corp.) from
passage 2 were seeded at a density of 1  105 per insert onto
24-mm, uncoated, semipermeable Transwell clear membranes (Costar) in
serum-free hormone- and growth factor–supplementedmedium (all medium
supplements were purchased from Clonetics). NHTBE cell cultures were
maintained in RA (5  108 mol/L)–sufficient media for mucociliary
differentiation and in RA-deficient media for squamous metaplasia
differentiation. NHTBE cells were grown submerged for the first 7 days, after
which time, the air-liquid interface was created. The cells were then cultured
in the air-liquid interface condition for 3 weeks, with medium changed every
24 h, as previously described (5, 9). Twenty-eight-day-old cultures with a fully
developed mucociliary and squamous metaplasia phenotype were used in all
experiments. The ASF ( for secretome analysis of the extracellular protein
pool) and whole-cell lysates ( for proteome analysis of the cellular protein
pool) were collected and stored at 80jC until needed.
The non–small-cell lung cancer cell lines NCI-H226, NCI-H292, NCI-
H1734, and NCI-H1975 were obtained from the American Type Culture
Collection. The cells were grown in a monolayer culture in RPMI 1640
containing 10% fetal bovine serum.
The cell lines for the in vitro lung carcinogenesis model, including
normal immortalized (BEAS-2B and 1799), transformed (1198), and
tumorigenic (1170-I) human bronchial epithelial cell lines, were obtained
from Dr. Klein-Szanto (Fox Chase Cancer Center, Philadelphia, PA). All of
the human bronchial epithelial cells were grown in keratinocyte serum-free
medium (Life Technologies, Gaithersburg, MD) containing epidermal
growth factor and bovine pituitary extract, as previously described (10).
All cells were cultured at 37jC in a humidified, water-jacketed incubator in
5% CO2 in air.
Preparation and analysis of protein extracts. To analyze protein
expression patterns in the ASF, the apical surfaces of the 4-week cultures of
NHTBE cells were vigorously washed with PBS containing EDTA-free
complete protease inhibitor cocktail (Roche Applied Science) and then the
ASF of mucous and squamous metaplastic NHTBE cells was collected. Next,
to extract the proteins from the ASF, trichloroacetic acid, at a final
concentration of 20%, was added to the thawed ASF, and the mixture was
incubated for 15 min on ice and then centrifuged at 10,000  g at 4jC for 15
min. The pellet was then washed with cold acetone, allowed to air-dry, and
resuspended in rehydration buffer containing 7 mol/L urea, 2 mol/L
thiourea, 4% (w/v) 3-[(3-cholamidopropyl)dimethylamino]-1-propanesul-
fonic acid, 100 mmol/L DTT, 0.1% (w/v) BioLytes (Bio-Rad Laboratories),
and a trace amount of bromophenol blue. Insoluble materials were removed
by centrifugation.
To analyze protein expression patterns in whole-cell lysates, the cells
were removed immediately and stored at 80jC after being frozen in liquid
nitrogen before their preparation for two-dimensional PAGE analysis. The
cells were collected and homogenized in 500 AL of lysis buffer [7 mol/L
urea, 2 mol/L thiourea, 2% CHAPS, 2% Pharmalyte (pH 3–10), 100 mmol/L
DTT] containing complete EDTA-free protease inhibitors (Roche Diagnos-
tics). The solubilized proteins were separated from nonsolubilized cellular
components by centrifugation (12,000  g at 4jC for 1 h). The supernatant
was transferred into a new microcentrifuge tube.
The protein concentrations of ASF and whole-cell lysates were
determined using a detergent-compatible protein assay kit (Bio-Rad)
according to the manufacturer’s instructions.
Two-dimensional PAGE and image analyses. To analyze differential
protein expression, 200 Ag of protein extracted from the ASF and whole-cell
lysates were subjected to two-dimensional PAGE analysis as previously
described (11). The samples were loaded onto 11-cm immobilized pH
gradient strips (pH 3–10, nonlinear), which were rehydrated for 12 h at 50 V.
Isoelectric focusing was conducted using a Protean isoelectric focusing cell
system for 40,000 V/h according to the manufacturer’s instructions. Focused
strips were equilibrated with 6.0 mol/L urea, 20% (v/v) glycerol, 2% SDS,
2.5% acrylamide, and 0.2 mmol/L tributyl phosphine in 150 mmol/L Tris-
HCl (pH 8.8) for 1 h. The equilibrated strips were applied directly to 4% to
20% gradient SDS-PAGE gel (Criterion, Bio-Rad) and separated overnight at
a constant voltage of 40 V. For analytic purposes, the gels were silver stained
using a Silver Stain Plus kit (Bio-Rad) according to the manufacturer’s
instructions. The stained gels were scanned using a Fluor-S MultiImager
(Bio-Rad) and analyzed with PDQuest software V9.0 (Bio-Rad). The images
were exported in the form of 16-bit tagged image file format files for
analysis. The digitalized images of differentially expressed protein spots
were compared using a color channel matching method with the PDQuest
software.
Identification of differentially expressed proteins. After being
excised, the silver-stained spots were destained by the method of Switzer
et al. (12) and digested in gel with 200 ng of modified trypsin (Promega).
The resulting peptides were analyzed by nano-liquid chromatography-
tandem mass spectrometry with on-line desalting with a Famos
autosampler, an Ultimate nano-LC module, and a Switchos precolumn
switching device (LC Packings/Dionex). Electrospray ion-trap mass
spectrometry was done using an LTQ linear ion-trap mass spectrometer
(Thermo). The fragment spectra were analyzed using the National Center
for Biotechnology Information nonredundant protein database and the
Mascot search engine (Matrix Science).
Western blot and dot-blot analyses. To determine endogenous protein
expression levels, we prepared whole-cell lysates using 2 SDS Laemmli
lysis buffer [250 mmol/L Tris-HCl (pH 6.5), 2% SDS, 4% h-mercaptoethanol,
0.02% bromophenol blue, and 10% glycerol]. Equal amounts of each lysate
(20 Ag) were resolved by 10% SDS-PAGE and transferred to nitrocellulose
membranes (Bio-Rad). The membranes were blocked with 5% skim milk in
PBST (PBS containing 0.1% Tween 20) for 1 h at room temperature and then
incubated overnight with primary antibody in PBST containing 2.5% bovine
serum albumin. The membranes were then washed with PBST and
incubated for 1 h at room temperature with peroxidase-conjugated
secondary antibody (Pierce) and visualized using an enhanced chemilumi-
nescence system (Amersham Biosciences). Equal protein loading was
confirmed by stripping the blots and reprobing them with antibody against
h-actin (Sigma-Aldrich).
Mouse anti-human monoclonal antibodies against SCCA1 and SCCA2
were purchased from Santa Cruz Biotechnology. Mouse anti-human
monoclonal antibodies against S100A8, S100A9, Annexin I, and Annexin II
were purchased from Transduction Laboratories. To determine the
proportion of each secreted protein in the ASF, equal volumes of ASF or
the medium from the cultured NHTBE cells were applied to nitrocellulose
membranes using a Minifold I dot-blot system (Schleicher & Schuell), and
then dot-blotting was done.
Tissue microarrays construction and immunohistochemical stain-
ing. The Tissue Bank at M.D. Anderson Cancer Center from 1997 to 2001
was searched for formalin-fixed, paraffin-embedded material from surgi-
cally resected lung cancer tissue specimens. The specimens obtained from
303 non–small-cell lung cancer cell lines were histologically examined,
classified using the 2004 WHO classification, and selected for tissue
microarray construction. They consisted of 114 squamous cell carcinomas
and 189 adenocarcinomas. Use of the specimens for research was approved
by our institutional review board. After histologic examination, tumor tissue
microarrays were prepared using triplicate 1-mm-diameter cores per tumor,
obtaining tissues from central, intermediate, and peripheral tumor areas. In
five cases from each tumor histology, adjacent normal bronchial epithelia
were also selected for immunohistochemical expression analysis using
whole-section specimens. Five-micron histologic sections were deparaffi-
nized, hydrated, and pretreated for 5 min with proteinase K for antigen
retrieval. Peroxide blocking was done with 3% H2O2 at room temperature
for 15 min, followed by 10% bovine serum albumin in PBST for 30 min at
room temperature. The slides were incubated with mouse anti-human
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SCCA1 and mouse anti-human SCCA2 (Santa Cruz Biotechnology) at 1:50
dilution for 90 min at room temperature. After washing with PBS,
incubation with biotin-labeled secondary antibody was done for 15 min,
followed by incubation with a 1:40 solution of streptavidin-peroxidase for 15
min. The staining was then developed with 0.05% 3¶,3-diaminobenzidine
tetrahydrochloride that had been freshly prepared in 0.05 mol/L Tris buffer
(pH 7.6) containing 0.024% H2O2, and then the sections were counterstained
with hematoxylin, dehydrated, and mounted. As negative control, we used
the same specimens used as positive controls, replacing the primary
antibody with PBS. The specimens were examined for SCCA1 and SCCA2
immunohistochemical expression in tumor cells and normal bronchial
epithelial cells using light microscopy.
Immunofluorescence assays. SCCA1 and SCCA2 expression was
analyzed by immunofluorescence in non–small-cell lung cancer cells and
cell lines used in the in vitro lung carcinogenesis model (BEAS-2B, 1799,
1198, and 1170-I). The cells were grown in chamber slides until 60%
confluent and then fixed with 4% (v/v) paraformaldehyde in PBS for 20 min
at room temperature. The cells were then permeabilized with PBS
containing 0.5% Triton X-100, blocked in 5% normal goat serum for 1 h,
and incubated with antihuman SCCA1 and antihuman SCCA2 antibodies
(each diluted 1:500) for 2 h. After being washed with PBS, the cells were
further incubated with Alexa Fluor 488–conjugated goat anti-mouse
secondary antibody (Molecular Probes) for 1 h, and nuclei were counter-
stained with 4¶6¶-diamidino-2-phenylindole for 30 min. After being washed
again with PBS, the cells were mounted using a SlowFade antifading kit
(Molecular Probes). Finally, the stained cells were visualized under an
Axioskop 40 microscope (Carl Zeiss) and images were captured at 400
magnification and stored using Axiovision software (Carl Zeiss) according
to the manufacturer’s instructions.
Results
Collection of ASF from normal mucociliary differentiated
and squamous metaplastic primary NHTBE cell cultures. To
investigate the differentially expressed proteins in ASF, we cultured
NHTBE cells with or without RA using a three-dimensional air-
liquid interface culture method. NHTBE cells cultured with RA
differentiated into mucous and ciliated differentiated cells
(Fig. 1A). In contrast, NHTBE cells cultured without RA differen-
tiated into squamous metaplastic cells that showed typical
squamous cell layers (Fig. 1B). In this system, the basal and apical
compartments of confluent cell cultures are completely separated,
leaving the ASF free from the protein components in the culture
medium in the basal compartment. The NHTBE cell cultures
develop fully differentiated mucociliary epithelia when maintained
in serum-free medium supplemented with RA and growth factors
in the basal compartment and exposed to air on the apical
side. Proteins in the basal compartment medium are prevented
from leaking into the apical side by the tight junctions in the
epithelial cell layer. Thus, unlike the secreted proteins from the
bronchial surface fluid in vivo , ASF from cultured bronchial
epithelial cells contains proteins secreted only by bronchial
epithelial cells.
Identification of differentially expressed proteins in squa-
mous NHTBE cells. As a first step toward identifying proteins that
are differentially represented in the ASF from squamous meta-
plastic NHTBE cells, we determined protein expression profiles
with independent secretomes and proteomes of mucous and
squamous differentiated NHTBE cells using two-dimensional PAGE
analysis.
We found that a small proportion (f40%) of the secreted
proteins appeared to be intracellular proteins (data not shown).
However, a substantial proportion of secreted proteins were
uniquely represented in the ASF from squamous and mucous
cultures compared with their respective intracellular proteomes
(Fig. 2A). For example, for the squamous differentiated NHTBE
cells, image analysis showed that only 39% of the spots from the
extracellular ASF secretome (Fig. 2A-a, red) and intracellular
proteome (d ; green) overlapped (g ). Similarly, for the mucous
Figure 1. Histologic presentation of mucociliary and
squamous metaplastic NHTBE cell cultures maintained by
a three-dimensional organotypic air-liquid interface culture
method. A, histomorphologic appearance of NHTBE cell
cultures grown with (A ) or without (B) RA for 4 wks. After
4 wks in culture, ASF and whole-cell lysates of the mucous
and squamous differentiated NHTBE cells were prepared
and analyzed as described in Materials and Methods.
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Figure 2. Comparison of protein
expression in squamous and mucous
differentiated NHTBE cells determined
by two-dimensional PAGE analysis.
A, representative images from two-
dimensional PAGE analysis showing ASF
from squamous differentiated NHTBE cells
(a ; red channel ); ASF from mucous
differentiated NHTBE cells (b ; green
channel ); merged images of a and b (c );
whole-cell lysate from squamous
differentiated NHTBE cells (d ; green
channel ); whole-cell lysate from mucous
differentiated NHTBE cells (e ; red channel );
merged image of d and e (f ); merged
image of a and d (g ); and merged image of
b and e (h). Representative of three
independent experiments. B, representative
two-dimensional PAGE images of ASF
from squamous differentiated NHTBE cells.
Arrows with annotations, protein spots
identified by liquid chromatography-tandem
mass spectrometry. The identified
proteins are listed in Table 1.
Cancer Research
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differentiated NHTBE cells, only 40% of the spots matched when
the secretome (b ; green) and proteome (e ; red) matched (h). These
results clearly indicated that a unique panel of proteins could be
detected in the ASF that were not detected intracellularly by two-
dimensional PAGE.
Comparative image analysis of the secretomes and proteomes
of squamous and mucous NHTBE cells revealed considerable
discrepancy. Only 35% of the spots matched in the secretomes of
the two cultures (Fig. 2A-c). Similarly, only 41% of the spots
matched in the proteomes of the two cultures (Fig. 2A-f ). The
analysis yielded more than 174 protein spots that seemed to be
expressed differently in the ASF from the squamous differentiated
NHTBE cells but not in the ASF from the mucous differentiated
NHTBE cells. Of those 174 proteins, 64 well-separated protein spots
were isolated, processed, and identified by liquid chromatography-
tandem mass spectrometry. A summary of all matches identified
for each spot is presented in Table 1, and the corresponding spots
are labeled in Fig. 2B . As shown in Fig. 2B , we found more than 11
spots [isoelectric point (pI), 5.5–7.55] of SCCA1 and SCCA2
proteins, which were expressed in squamous cell but not mucous
cell ASF. In addition, S100A8, S100A9, Annexin I, and Annexin II
were identified in the squamous cell ASF but not in the mucous
cell ASF.
Validation of differentially expressed proteins in ASF. To
verify the differential expression of proteins in the squamous cell
ASF, we used dot-blot analysis to examine the expression of a
selected panel of proteins, including SCCA1, SCCA2, S100A8,
S100A9, Annexin I, and Annexin II, in the ASF from squamous and
mucous NHTBE cells. The selected proteins were detected only in
the ASF from squamous differentiated NHTBE cells (Fig. 3A). The
presence of the MUC5AC protein in the ASF was used as an
indicator of mucous differentiation of NHTBE cells because
MUC5AC is exclusively produced by the mucous goblet cells in
the bronchial epithelia.
We next examined the cellular expression of the selected
proteins by Western blot analysis. SCCA1 and SCCA2 were
expressed only in squamous differentiated cells (Fig. 3B). S100A8
and S100A9 were much more highly expressed in squamous
differentiated cells than in mucous differentiated cells. In contrast,
Annexin I and Annexin II were expressed at the same intracellular
levels in both cell types, despite being detected only in the
squamous cell ASF.
Together, these results clearly showed that SCCA1 and SCCA2 in
the ASF are secreted markers of metaplastic squamous differen-
tiation in bronchial epithelial cells.
SCCA1 and SCCA2 expression levels in transformed and
tumorigenic human bronchial epithelial cells and non–small-
cell lung cancer cells. To further investigate whether SCCA1 and
SCCA2 expression is abnormally regulated during lung carcino-
genesis, we measured the expression of these proteins in an
in vitro lung carcinogenesis model. The system was composed of
syngeneic cell lines: the immortalized human bronchial epithelial
cell lines BEAS-2B and 1799 and the tumorigenic cell lines 1198
(transformed) and 1170-I (tumorigenic). Western blot (Fig. 4A)
and immunofluorescence (Fig. 4B) analyses showed that SCCA1
expression and SCCA2 expression were much higher in
tumorigenic cell lines (1198 and 1170-I) than in the BEAS-2B
and 1799 cell lines. These results showed that expression of
these proteins increased during progression to the tumorigenic
phenotype.
To confirm the elevated expression of SCCA1 and SCCA2 in
tumorigenic cell lines, we next examined the expression of
SCCA1 and SCCA2 in four established non–small-cell lung
cancer cell lines (two squamous cell carcinomas and two
adenocarcinomas). Western blotting (Fig. 4C) and immunofluo-
rescence (Fig. 4D) analyses showed that SCCA1 and SCCA2
were expressed only in the squamous cell carcinoma cell lines
(H226 and H292); their expression was undetectable in the
Table 1. Uniquely expressed proteins in ASF from squamous metaplastic NHTBE cells
Spot Protein Accession no. M r (kDa) pI Mascot scores Identified peptide no.
1 S100A8 NP_002955 10.9 6.7 692 10
2 Cystatin B AAF44059 15.2 5.9 566 5
3 S100A9 NP_002956 13.2 5.6 547 14
4 S100A14 NP_065723 11.6 5.4 102 11
5 Chain A, cyclophilin A complexed with cyclosporin A 3CYSA 17.9 8.1 227 9
6 Annexin I NP_000691 37.3 8.1 157 5
7 Annexin II NP_004030 36.6 8.5 149 9
8 SCCA1 P29508 42.1 5.3 809 19
9 SCCA2 P48594 42.1 7.0 843 18
10 Maspin precursor (protease inhibitor 5) P36952 42.0 5.2 377 5
11 Phosphoglycerate kinase 1 P00558 45.0 8.5 939 17
12 Trifunctional enzyme a subunit P40939 78.0 9.0 144 13
13 60-kDa heat shock protein P10809 60.0 4.5 567 8
14 70-kDa heat-shock protein 8 isoform 1 NP_006588 69.7 8.0 663 9
15 Cytosolic thyroid hormone-binding protein P14618 57.3 8.5 186 3
16 Protein disulfide-isomerase precursor P02737 55.0 4.0 486 14
17 ATP5A1 protein AAH39135 60.9 8.5 826 14
18 Purine nucleoside phosphorylase P00491 31.2 5.6 188 15
19 Porin 31HM AAB20246 32.8 8.8 289 4
20 PRO2044 AAF22034 29.0 6.0 102 2
21 Chain B, triose phosphate isomerase 1HTIB 26.7 6.5 610 9
22 Cytochrome B-245 heavy chain P04839 20.5 4.0 301 5
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adenocarcinoma cell lines (H1734 and H1975). These results
showed that SCCA1 and SCCA2 are expressed only in squamous
cell carcinoma cell lines.
SCCA1 and SCCA2 expression levels in normal and
malignant lung tissue specimens. To determine whether SCCA1
and SCCA2 expression is also elevated in non–small-cell lung
cancer tissue specimens and the specificity of these proteins
expression in adenocarcinoma and squamous cell carcinoma
histologies, we did immunohistochemical analysis using tumor
tissue microarray samples (Fig. 5). As shown in Fig. 5, SCCA1 and
SCCA2 immunostainings were detected in the cytoplasm of
tumor cells in both tumor histology specimens. However, the
protein expression frequency was obviously higher in squamous
cell carcinoma [positive, SCCA1 42.4% (n = 45) and SCCA2
65.7% (n = 69); negative, SCCA1 57.6% (n = 61) and SCCA2
34.3% (n = 36)] compared with adenocarcinoma [positive, SCCA1
33.3% (n = 58) and SCCA2 39.8% (n = 70); negative, SCCA1 66.7%
(n = 116) and SCCA2 60.2% (n = 106)] histology, especially for
SCCA2. In contrast, the expression of the two proteins was
undetectable in normal bronchial epithelia adjacent to tumors
from each histology (Fig. 5, top). These results indicate that
SCCA1 and SCCA2 are not expressed in normal bronchial
epithelium and they are highly expressed in squamous cell
carcinoma of the lung. Somewhat surprising, approximately one
third of adenocarcinomas showed SSCA1 and SCCA2 immuno-
histochemical expression.
Discussion
The discovery of new biomarkers holds promise for the early
detection of precancerous lesions and the potential to reduce
cancer mortality. However, no systematic approach has been
applied to study the composition of the secretory proteome of
bronchial epithelia cells. To accomplish this goal, we have applied a
novel in vitro approach to identify new biomarkers using primary
bronchial epithelial cells cultured by the organotypic air-liquid
interface method, which allows the development of normal
mucociliary cells or squamous metaplasia depending on the
presence or absence of RA (5). Similarly, a previous study showed
that the secretory protein profiles of adipose cells from the
epididymal, inguinal, and omental fat pads of male rats differ from
the protein profiles of whole-cell lysates (13).
Comparative analysis of the secretomes in the ASF from
squamous and mucous NHTBE cells revealed at least 22 proteins
that were unique in the ASF from squamous metaplastic NHTBE
cells. Six proteins (SCCA1, SCCA2, S100A8, S100A9, Annexin I, and
Annexin II) were initially selected for verification and further
characterization because these proteins were implicated in cancer
as described below.
Particularly, SCCA1 and SCCA2 were of interest because of
increasing number of reports suggesting that SCCA may be a
marker for squamous cell carcinoma. For example, SCCA has
been implicated as a circulating tumor marker for squamous cell
carcinoma of the cervix, head and neck, lung, and esophagus
(14–17). Body et al. (18) reported elevated SCCA levels in patients
with advanced lung cancer. Several studies show that increased
serum SCCA levels correlated with advance lung cancer (19–23).
In a previous study, it was reported that SCCA levels are
increased in squamous cell carcinoma patients with correlation of
disease extension (24). Consistent with our results, it was also
reported that overexpression of SCCA1 and SCCA2 was found in
43% of lung tumors compared with corresponding normal tissue
(25). In addition, overexpression of SCCA2 to SCCA1 was
proposed as a marker of squamous cell carcinoma of the lung
(26). However, our finding of approximately one third of
adenocarcinomas showing SCCA1 and SCCA2 immunohistochem-
ical expression suggests that these markers are not specific for
lung squamous cell carcinoma. Nevertheless, it is noteworthy that
the expression of SCCA1 and SCCA2 was low or undetectable
in normal bronchial epithelia adjacent to tumors, and expression
of the two proteins was obviously higher in squamous cell
carcinoma (SCCA1, 42.4%; SCCA2, 65.7%) compared with adeno-
carcinoma (SCCA1, 33.3%; SCCA2, 39.8%) histology, especially for
SCCA2.
Interestingly, the expression of the two proteins was also
gradually augmented with increasing malignancy in lung carcino-
genesis model cell lines, and the two proteins were overexpressed
in non–small-cell lung cancer cell lines. This result is somewhat
consistent with previous reports that SCCA is not present in
respiratory secretions from the normal epithelium of the lung (27)
but is present in secretions from areas of squamous metaplasia in
the lung (28). Although SCCA activity was previously detected in
inflammatory lung disease (27), SCCA may be secreted from
nonsquamous epithelial cells undergoing squamous metaplastic
changes in response to severe inflammation. Our finding that the
expression of SCCA1 and SCCA2 increased with increasing
malignancy suggests that the two proteins are associated with
tumor progression. Thus, the presence of SCCA in the ASF of
epithelial cells undergoing early abnormal changes suggests that
SCCA1 and SCCA2 can be used as biomarkers for early detection of
premalignant bronchial lesions and lung squamous cell carcinoma.
However, further analysis of the expression of these two makers in
Figure 3. Dot-blot andWestern blot analyses of differentially expressed proteins.
ASF and whole-cell lysates from squamous differentiated (RA ) and mucous
differentiated (+RA ) NHTBE cells were analyzed by dot-blot (A ) and Western blot
(B) analyses as described in Materials and Methods. MUC5AC was used as an
indicator of mucous cell differentiation. h-Actin was used as a loading control for
Western blot analysis. Representative of three independent experiments.
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preneoplastic lesions for both squamous cell carcinoma and
adenocarcinoma of the lung is needed.
The second pair of proteins we examined, S100A8 and S100A9,
belong to the S100 family, one of the largest subfamilies of the
elongation factor-hand calcium-binding proteins (29, 30). Al-
though the role of these proteins in squamous metaplasia is not
known, S100 family proteins have been shown to be involved in
metastasis of cancer cells. For example, S100A6, S100A8, S100A9,
and S100A11 are overexpressed in lung cancer and are involved
in migration of cancer cells during metastasis (31, 32).
The other proteins we examined were Annexins I and II. Annexin
I has been shown to be involved in membrane fusion, intracellular
signal transduction, and cell differentiation. This protein is not
found in normal tissue but is present in various tumor vessels (33)
and diffusely in neoplastic lung tissue (34). Although Annexin I is a
major component of the cilia of human bronchial cells and a fetal
lung marker that is a substrate of the epidermal growth factor
receptor (33, 35, 36), we found it only in the ASF of squamous
NHTBE cells, not in the ASF of mucous NHTBE cells. It is not
known how and why squamous NHTBE cells secrete Annexin I.
Figure 4. Expression of SCCA1 and SCCA2 in syngeneic in vitro lung carcinogenesis model cell lines and non–small-cell lung cancer cell lines. A, equal amounts of
whole-cell lysates isolated from immortalized human bronchial epithelial cells (BEAS-2B and 1799), transformed cells (1198), and malignant cells (1170-I) were
subjected to Western blot analysis with anti-SCCA1 and anti-SCCA2 antibodies. B, cells grown on chamber slides were subjected to immunofluorescence analysis with
the same antibodies. Nuclei were stained with 4¶6¶-diamidino-2-phenylindole (DAPI) and the images were merged. C, equal amounts of whole-cell lysates from
non–small-cell lung cancer cell lines (squamous cell carcinoma cell lines H226 and H292 and adenocarcinoma cell lines H1734 and H1975) were subjected to Western
blot analysis with anti-SCCA1 and anti-SCCA2 antibodies. D, cells grown on chamber slides were subjected to immunofluorescence analysis with the same antibodies.
Nuclei were stained with DAPI and the images were merged. Representative of three independent experiments.
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Whereas the role of Annexin II in lung cancer has not been clearly
elucidated, autoantibodies against it have been detected in sera
from lung cancer patients (37).
Only some of the proteins that we identified in this study as being
secreted from squamous metaplastic bronchial epithelial cells were
reported in previous studies of biomarkers for early lung cancer
(38, 39). This discrepancy may be related to the sources of the
samples and the model system used. Our organotypic air-liquid
interface NHTBE cell culture system, which recapitulates in vivo
mucociliary differentiated bronchial epithelium, has several advan-
tages over the approaches used in other studies that have relied on
cancer tissues or body fluids. NHTBE cells cultured by this method
develop a squamous metaplastic phenotype when the cells are
maintained in RA-deficient medium, whereas the same NHTBE cells
develop a mucociliary phenotype in RA-sufficient medium. Thus,
heterogeneity due to different cell types is excluded. In addition, the
basal medium and ASF of confluent cell cultures are completely
separated, meaning that the ASF is not contaminated with or
diluted by the protein components in the culture medium in the
basal compartment. Finally, the proteins in the ASF are secreted
only from homogeneous bronchial epithelial cells and also enriched
without dilution by culture medium or other types of cells, whereas
the proteins in bronchial lavage fluid or cancer tissue specimens
include many proteins derived from various cell types, such as
stromal cells, inflammatory cells infiltrating cancer tissues, and
circulating blood cells.
However, there is a potential limitation to our study. We used
cultured squamous metaplastic NHTBE cells as a model for early
abnormal changes indicative of carcinogenesis, but the classifica-
tion of metaplastic lesions as precancerous has been controversial
(40, 41). For example, metaplastic lesions are frequently associated
with chronic inflammation, and they can be induced by
mechanical trauma. In addition, the molecular changes in these
lesions are similar to those in histologically normal epithelial cells
in chronic smokers. It is also not clear whether the presence of
such lesions indicates an increased risk for developing lung
cancer. Nonetheless, the development of squamous cell lung
cancer involves a series of morphologically distinct changes, often
progressing from hyperplasia to metaplasia, dysplasia, and finally
carcinoma in situ (42).
Although we verified only six of 22 proteins, the other proteins
we identified in the ASF (e.g., cyclophilin, cystatin, heat shock
proteins, and maspin) are also reportedly associated with
carcinogenesis or lung cancer progression (25, 43–46). Additional
studies are needed to elucidate the potential of this larger panel of
proteins to be biomarkers for the early detection of premalignant
squamous cell carcinoma lesions.
In conclusion, we identified 22 proteins that were overexpressed
in the ASF from cultured squamous NHTBE cells but not in the
ASF from mucous NHTBE cells. We further characterized the
overexpression of six of these proteins—SCCA1, SCCA2, S100A8,
S100A9, Annexin I, and Annexin II—in the ASF from squamous and
mucous NHTBE cells. Our findings suggest that proteins secreted
from bronchial epithelial cells are potential markers of early
squamous metaplastic or precancerous changes. However, further
retrospective and prospective studies are required to determine
whether these proteins are aberrantly overrepresented in bronchial
secretions from patients who are at high risk of developing lung
cancer. Our approach involving analysis of ASF from primary
bronchial epithelial cells using organotypic air-liquid interface
culturing can be extended to other types of cells, such as
adenocarcinoma or squamous cell carcinoma, to identify proteins
secreted directly from cancer cells without interference from the
culture medium.
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Figure 5. Microphotographs showing immunohistochemical expression of
SCCA1 and SCCA2 in normal bronchial epithelium and non–small-cell lung
cancer tumor tissue microarray tissue specimens. Normal bronchial epithelium
(A and B ), adenocarcinoma (C–F ), and squamous cell carcinoma (G–J ) tissue
sections were subjected to immunohistochemical analysis with antihuman
SCCA1 (left ) and antihuman SCCA2 (right ) antibodies. As negative control, we
used the same specimens used as positive controls, replacing the primary
antibody with PBS (C, D, G , and H ). N, normal bronchial epithelium;
AD, adenocarcinoma; SC, squamous cell carcinoma.
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